Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy

NeuroReport

Volumn 9, Issue 8, 1998, Pages 1817-1822

  Tseng, Jack L ^a   Bruhn, Suzanne L ^b   Zurn, Anne D ^a   Aebischer, Patrick ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CytoTherapeutics Incorporated   (United States)

Author keywords

MFB axotomy; Neurturin; Parkinson's disease; Polymer encapsulation; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; NEUROTROPHIC FACTOR; NEURTURIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MEDIAL FOREBRAIN BUNDLE; NERVE FIBER TRANSECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0032102162     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199806010-00027     Document Type: Article

References (34)

1. Kotzbauer PT, Lampe PA, Heuckeroth RO et al. Nature 384, 467-470 (1996).
2. Lin L-FH, Doherty DH, Lile JD et al. Science 260, 1130-1132 (1993).
3. Klein RD, Sherman D, Ho W-H et al. Nature 387, 717-721 (1997).
4. Wang L-C, Poulsen K, Milbrandt J et al. Soc Neurosci Abstr 23, 354.1 (1997).
5. Durbec P, Marcos-Gutierrez CV, Kilkenny C et al. Nature 381, 789-793 (1996).
6. Jing S, Wen D, Yu Y et al. Cell 85, 1113-1124 (1996).
7. Treanor JJS, Goodman L, de Sauvage F et al. Nature 382, 80-83 (1996).
8. Trupp M, Arenas E, Fainzilber M et al. Nature 381, 785-789 (1996).
9. Buj-Bello A, Adu J, Pinón LGP et al. Nature 387, 721-724 (1997).
10. Sanicola M, Hession C, Worley D et al. Proc Natl Acad Sci USA 94, 6238-6243 (1997).
11. Widenfalk J, Nosrat C, Tomac A et al. J Neurosci 17, 8506-8519 (1997).
12. GFRα Nomenclature Committee. Neuron 19, 485 (1997).
13. Creedon DJ, Tanney MG, Baloh RH et al. Proc Natl Acad Sci USA 94, 7018-7023 (1997).
14. Trupp M, Belluardo N, Funakoshi H et al. J Neurosci 17, 3554-3567 (1997).
15. Baloh R, Tansey M, Golden J et al. Neuron 18, 793-802 (1997).
16. Suvanto P, Wartiovaara K, Lindahl M et al. Hum Mol Genet 6, 1267-1273 (1997).
17. Henderson CE, Phillips HS, Pollock RA et al. Nature 266, 1062-1064 (1994).
18. Zurn AD, Baetge EE, Hammang JP et al. NeuroReport 6, 113-118 (1994).
19. Yan Q, Matheson C and Lopez OT. Nature 373, 341-344 (1995).
20. Sagot Y, Tan SA, Hammang JP et al. J Neurosci 16, 2335-2341 (1996).
21. Beck KD, Valverde J, Alexi T et al. Nature 373, 339-341 (1995).
22. Bowenkamp KE, Hoffman AF, Gerhardt GA et al. J Comp Neurol 355, 479-489 (1995).
23. Sauer H, Rosenblad C and Bjorklund A. Proc Natl Acad Sci USA 92, 8936-8939 (1995).
24. Tomac A, Lindqvist E, Lin L-FH et al. Nature 373, 335-339 (1995).
25. Gash DM, Zhang Z, Ovadia A et al. Nature 380, 252-255 (1996).
26. Tseng JL, Baetge EE, Zurn AD et al. J Neurosci 17, 325-333 (1997).
27. Aebischer P, Tresco PA, Winn SR et al. Exp Neurol 111, 269-275 (1991).
28. Higuchi R. Recombinant PCR, In: Innis MA, Gelfand DH, Sninsy JJ et al. PCR Protocols: A Guide to Methods and Applications. New York: Academic Press, 1990: 177-183.
29. Kozak M. Nucl Acids Res 16, 8125-8132 (1987).
30. Rinsch C, Régulier E, Déglon N et al. Hum Gene Ther 8, 1881-1889 (1997).
31. Knüsel B, Beck KD, Winslow JW et al. J Neurosci 12, 4391-4402 (1992).
32. Hagg T and Varon S. Proc Natl Acad Sci USA 90, 6315-6319 (1993).
33. Lapchak PA, Beck KD, Araujo DM et al. Neuroscience 53, 639-650 (1993).
34. Abercrombie M. Anat Rec 34, 239-247 (1946).